Lanean...
Transcellular movement of hydroxyurea is mediated by specific solute carrier transporters
OBJECTIVE: Hydroxyurea has proven laboratory and clinical therapeutic benefits for sickle cell anemia (SCA) and other diseases, yet many questions remain regarding its in vivo pharmacokinetic and pharmacodynamic profiles. Previous reports suggest that hydroxyurea passively diffuses across cells, but...
Gorde:
| Argitaratua izan da: | Exp Hematol |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2011
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4739778/ https://ncbi.nlm.nih.gov/pubmed/21256917 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.exphem.2011.01.004 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|